Bachem Holding AG
BANB
Rank in Stocks
#2516
Bachem Holding AG serves pharmaceutical and biotechnology companies globally,... Bachem Holding AG serves pharmaceutical and biotechnology companies globally, providing products crucial for research, clinical development, and commercial use. The company's primary focus is on the design, manufacturing, and regulatory support for peptide active pharmaceutical ingredients (APIs), specifically targeting novel peptide and oligonucleotide chemical entities (NCEs). Additionally, Bachem offers commercially available NCEs and generic compounds. Its comprehensive service portfolio includes project management, quality assurance and regulatory guidance, analytical testing, production adhering to Good Manufacturing Practices (GMP), manufacturing for research purposes, and expertise in supply chain and vertical integration. Established in 1971, Bachem Holding AG is headquartered in Bubendorf, Switzerland, and functions as a subsidiary of Ingro Finanz AG.
Share Price
$100.60
Market Cap
$7.54B
Change (1 day)
-1.49%
Change (1 year)
49.53%
Country
CH
Trade Bachem Holding AG (BANB)
Category
Healthcare
EPS for Bachem Holding AG (BANB)
EPS as of 2026 TTM: 0
According to Bachem Holding AG latest financial reports and stock price the company's current EPS (TTM) is 0. At the end of 2026 the company had a EPS of 0 equal to its 2026 EPS that were of 0.
EPS history for Bachem Holding AG from 2002 to 2026
EPS at the end of each year
| Year | EPS | Change |
|---|---|---|
| 2025 | $2.50 | 40.86% |
| 2024 | $1.77 | -0.69% |
| 2023 | $1.78 | 20.37% |
| 2022 | $1.48 | -16.61% |
| 2021 | $1.78 | 42.52% |
| 2020 | $1.25 | 54.63% |
| 2019 | $0.81 | 14.96% |
| 2018 | $0.70 | 10.27% |
| 2017 | $0.64 | 6.14% |
| 2016 | $0.60 | 27.46% |
| 2015 | $0.47 | 8.62% |
| 2014 | $0.43 | 10.38% |
| 2013 | $0.39 | 56.07% |
| 2012 | $0.25 | 68.66% |
| 2011 | $0.15 | -66.84% |
| 2010 | $0.45 | -32.70% |
| 2009 | $0.67 | -18.95% |
| 2008 | $0.82 | -3.00% |
| 2007 | $0.85 | 45.84% |
| 2006 | $0.58 | 27.75% |
| 2005 | $0.46 | 10.28% |
| 2004 | $0.41 | -8.68% |
| 2003 | $0.45 | 25.23% |
| 2002 | $0.36 | 0.00% |
EPS for similar companies or competitors
| Company | EPS | EPS Difference | Country |
|---|---|---|---|
| $17.32 | - |
US
|
|
| $-7.98 | - |
US
|
|
| $-5.29 | - |
AU
|
|
| $27.74 | - |
NL
|
|
| - | - |
CH
|
